Disease Risk Scores to Evaluate Heterogeneous Treatment Effects of Ibuprofen Associated Acute Kidney Injury in Hospitalized Patients

Date:

I gave a podium presentation on using disease risk scores to evaluate heterogeneous treatment effects of ibuprofen-associated acute kidney injury in hospitalized patients at the 2026 International Society for Pharmacoepidemiology Annual Meeting in Milan. This project began as a methods question and grew into a dissertation exploring how we can better understand who is most likely to benefit from—and be harmed by—medications. Presenting the work in Milan was a fitting way to close out that chapter of my training.